MarketInOut Stock Screener Log In | Sign Up
 

Anteris Technologies Global Corp

IEX • Healthcare • Medical Devices • Quote as of 05/14/2026 15:59
Anteris Technologies Global Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeIEX
Market Capitalization633.95 mln
Float78.53 mln
Earnings Date05/19/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-8.05
Highly reliable

Relative Strength

94 / 100
Top performer

Debt / Equity

-24.54
Negative equity

ROE

-351
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through less invasive procedures. Its flagship product, the DurAVR system, is a catheter-delivered heart valve designed to replicate the natural function of a healthy aortic valve. The company also offers supporting technologies, including a tissue treatment process that improves durability and a specialized delivery system that helps surgeons navigate the heart with greater precision and control.

Key Fundamentals

EPS-2.55
ROE-351
RPS0.05
ROIC-1,128
ROA-213
EBITDA, mln-92.49
EV / EBITDA-5.84
EV / EBIT-5.73
Revenue, mln1.91
EV / Revenue282

Financial Strength

Altman Z-Score-22.28
Piotroski F-Score 3 / 9
Beneish M-Score-8.05
Short Ratio3.96
Short % of Float6.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.52% 95 / 100   
1 Month 15.42% 88 / 100   
2 Months 38.81% 90 / 100   
6 Months 93.6% 95 / 100   
1 Year 59.56% 79 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us